Experimental therapies in the treatment of cutaneous T-cell lymphoma

F. M. Foss*, T. M. Kuzel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Although meaningful clinical responses have been demonstrated in cutaneous T-cell lymphoma using a number of therapeutic modalities, survival benefits have not been demonstrated for the majority of patients. Several novel therapies, including retinoids, purine analogs, biologic response modifiers, monoclonal antibodies, and fusion toxins have demonstrated activity and clinical promise in early studies.

Original languageEnglish (US)
Pages (from-to)1127-1137
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume9
Issue number5
DOIs
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Experimental therapies in the treatment of cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Cite this